HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Tongue Cancer

Tongue Cancer

Tongue cancer, a subtype of oral cancer, poses a significant health challenge globally. Research in this field aims to enhance early detection methods and improve treatment outcomes. Innovative approaches such as immunotherapy show promise in targeting cancer cells while sparing healthy tissue, potentially reducing side effects compared to traditional treatments like chemotherapy and radiation. Moreover, advancements in genomic sequencing enable personalized treatment strategies tailored to the individual's genetic makeup, optimizing therapeutic efficacy. Prevention efforts also play a crucial role, emphasizing the importance of lifestyle modifications such as tobacco cessation and limiting alcohol consumption, which are major risk factors for developing tongue cancer. Through interdisciplinary collaboration and technological innovation, ongoing research endeavors strive to mitigate the burden of tongue cancer and improve patient prognosis.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp